HomeENLV • NASDAQ
add
Enlivex Therapeutics Ltd
Previous close
$0.98
Day range
$0.88 - $1.06
Year range
$0.83 - $2.10
Market cap
22.76M USD
Avg Volume
7.26M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.56M | -18.02% |
Net income | -2.20M | 15.26% |
Net profit margin | — | — |
Earnings per share | -0.09 | 25.00% |
EBITDA | -2.48M | 16.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.20M | -25.72% |
Total assets | 20.94M | -29.73% |
Total liabilities | 3.46M | 7.69% |
Total equity | 17.48M | — |
Shares outstanding | 24.29M | — |
Price to book | 1.36 | — |
Return on assets | -29.37% | — |
Return on capital | -33.90% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -2.20M | 15.26% |
Cash from operations | -1.97M | 24.80% |
Cash from investing | 3.82M | 173.09% |
Cash from financing | 352.00K | 40.80% |
Net change in cash | 2.20M | 326.70% |
Free cash flow | -1.04M | 28.40% |
About
Founded
Jan 22, 2012
Website
Employees
36
